UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

This study is testing whether tiny particles called exosomes derived from umbilical cord mesenchymal stem cells can help the bone marrow recover more quickly after chemotherapy in patients with acute myeloid leukemia (AML) — a blood cancer — who are in remission and receiving consolidation (follow-up) chemotherapy. Bone marrow suppression after chemo can lead to dangerous drops in blood cell counts. **You may be eligible if...** - You are between 18 and 60 years old - You have been diagnosed with acute myeloid leukemia (AML, excluding a subtype called M3/APL) - Your AML is in complete remission after initial treatment - You are about to begin consolidation chemotherapy (follow-up chemo to keep the cancer in remission) - Your general health and organ function are adequate **You may NOT be eligible if...** - You have AML subtype M3 (also known as APL) - You have active serious infections - You have serious liver, kidney, or heart problems - You are pregnant or breastfeeding - You have had a prior stem cell transplant Talk to your doctor to see if this trial is right for you.